Alto Neuroscience announces Phase 1 results for ALTO-101 to treat CIAS
In: The Fly, 2024-04-23
serialPeriodical
Zugriff:
Alto Neuroscience announced positive results from its healthy volunteer Phase 1 study of ALTO-101, a novel PDE4 inhibitor in development for cognitive impairment associated with schizophrenia CIAS. Results from the [...]
Titel: |
Alto Neuroscience announces Phase 1 results for ALTO-101 to treat CIAS
|
---|---|
Zeitschrift: | The Fly, 2024-04-23 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
Schlagwort: |
|
Sonstiges: |
|